- Home
- THRD vs CRNT Comparison
THRD vs CRNT Comparison
Compare THRD & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- CRNT
- Stock Information
- Founded
- THRD 2019
- CRNT 1996
- Country
- THRD United States
- CRNT Israel
- Employees
- THRD N/A
- CRNT N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- CRNT Radio And Television Broadcasting And Communications Equipment
- Sector
- THRD Health Care
- CRNT Technology
- Exchange
- THRD Nasdaq
- CRNT Nasdaq
- Market Cap
- THRD 335.2M
- CRNT 390.5M
- IPO Year
- THRD 2022
- CRNT 2000
- Fundamental
- Price
- THRD $6.00
- CRNT $4.53
- Analyst Decision
- THRD Strong Buy
- CRNT Strong Buy
- Analyst Count
- THRD 3
- CRNT 4
- Target Price
- THRD $20.33
- CRNT $6.44
- AVG Volume (30 Days)
- THRD 248.2K
- CRNT 2.1M
- Earning Date
- THRD 11-07-2024
- CRNT 02-18-2025
- Dividend Yield
- THRD N/A
- CRNT N/A
- EPS Growth
- THRD N/A
- CRNT N/A
- EPS
- THRD N/A
- CRNT 0.21
- Revenue
- THRD N/A
- CRNT $377,617,000.00
- Revenue This Year
- THRD N/A
- CRNT $15.29
- Revenue Next Year
- THRD N/A
- CRNT $5.78
- P/E Ratio
- THRD N/A
- CRNT $21.19
- Revenue Growth
- THRD N/A
- CRNT 13.62
- 52 Week Low
- THRD $5.60
- CRNT $2.33
- 52 Week High
- THRD $16.94
- CRNT $5.73
- Technical
- Relative Strength Index (RSI)
- THRD 23.75
- CRNT 49.25
- Support Level
- THRD $5.60
- CRNT $4.43
- Resistance Level
- THRD $11.78
- CRNT $4.98
- Average True Range (ATR)
- THRD 0.89
- CRNT 0.35
- MACD
- THRD -0.43
- CRNT -0.09
- Stochastic Oscillator
- THRD 6.50
- CRNT 13.04
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.